0001127602-23-019612.txt : 20230630 0001127602-23-019612.hdr.sgml : 20230630 20230630160451 ACCESSION NUMBER: 0001127602-23-019612 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221202 FILED AS OF DATE: 20230630 DATE AS OF CHANGE: 20230630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Romanelli Joseph CENTRAL INDEX KEY: 0001938322 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 231061657 MAIL ADDRESS: STREET 1: 126 EAST LINCOLN AVENUE CITY: RAHWAY STATE: NJ ZIP: 07065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0407 4 2022-12-02 0000310158 Merck & Co., Inc. MRK 0001938322 Romanelli Joseph MERCK & CO., INC. 126 EAST LINCOLN AVENUE RAHWAY NJ 07065 1 President, Human Health Int?l 0 Common Stock 2022-12-02 4 P 0 59 109.67 A 59 I By Spouse Common Stock 2022-12-05 4 P 0 107 109.54 A 20391.325 D Common Stock 2022-12-06 4 P 0 30 109.39 A 20421.325 D Common Stock 2022-12-13 4 P 0 56 110.96 A 20477.325 D Common Stock 2022-12-19 4 P 0 7 109.04 A 20484.325 D Common Stock 2023-02-21 4 P 0 11 109.20 A 20495.325 D Common Stock 2023-03-20 4 P 0 136 105.47 A 20631.325 D Common Stock 2023-03-24 4 S 0 35 104.65 D 20596.325 D Common Stock 2023-04-26 4 P 0 3 113.68 A 20599.325 D None of the purchases or sales reported herein were directed by the reporting person, but were executed by a brokerage firm for the benefit of the reporting person's managed account, without the reporting person's knowledge. One of the reported transactions resulted in a short swing profit under Section 16(b) of the Securities Exchange Act of 1934, as amended ("Section 16(b)"), and the reporting person has disgorged $374.01 to the Issuer, which amount represents all profits related to these transactions in accordance with Section 16(b). /s/ Jon Filderman, attorney-in-fact for Joseph Romanelli 2023-06-30